Sana Biotechnology (SANA) Shares Outstanding (2020 - 2026)

Sana Biotechnology's Shares Outstanding history runs 7 years deep, the most recent figure standing at $269.8 million for Q1 2026.

• In Q1 2026, Shares Outstanding rose 19.67% year-over-year to $269.8 million; the TTM figure through Mar 2026 stood at $269.8 million (up 19.67% YoY), while the FY2025 annual figure was $266.7 million, up 19.12% from the prior year.
• Shares Outstanding came in at $269.8 million for Q1 2026 at Sana Biotechnology, up from $266.7 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $269.8 million in Q1 2026 to a low of $186.6 million in Q1 2022.
• A 5-year average of $216.7 million and a median of $221.3 million in 2024 frame the typical range for Shares Outstanding.
• Across the five-year window, Shares Outstanding climbed 1.89% in 2025 and advanced 19.67% in 2026, its largest moves.
• Sana Biotechnology's Shares Outstanding stood at $191.0 million in 2022, then increased by 3.58% to $197.9 million in 2023, then increased by 13.17% to $223.9 million in 2024, then advanced by 19.12% to $266.7 million in 2025, then advanced by 1.16% to $269.8 million in 2026.
• According to Business Quant data, Shares Outstanding over the past three periods registered $269.8 million, $266.7 million, and $262.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison